
Please try another search
TWi Pharmaceuticals, Inc. is engaged in the development, commissioned manufacturing and commissioned research of special pharmaceuticals. The Company focuses on the development of two categories of high barrier generic drugs: Paragraph IV of Abbreviated New Drug Applications (ANDAs) and generics with high technical barriers. The Company is involved in the commissioned manufacture of Divalproex Sodium Extended Release Tablet, which are oral tablets used as antiepileptic drug; the commissioned research and development of generic drugs to meet its customer’s specific needs, and the manufacture and sale of oral tablets and capsules used for the treatment of hypertension, depression, and gastro esophageal reflux diseases. The Company distributes its products in the United States and Taiwan.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review